Tomasello Shawn
Director at Diplomat Pharmacy, Inc.; Chief Commercial Officer at Kite Pharma, Inc.
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Oct 2, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Diplomat Pharmacy, Inc.Director
- Kite Pharma, Inc.Chief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Kite Pharma, Inc.9,104 shares
- Diplomat Pharmacy, Inc.3,813 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Kite Pharma, Inc.Plan not statedDec 20 2016
Sold 4,901 shares at $50.86 ($249k)
Tomasello Shawn, Chief Commercial Officer
Sold 9% of holdings ($2.8M position)49,635 shares leftFirst sale on recordFiling
- 2 Form 4 sale Kite Pharma, Inc.Plan not statedSep 25 +279 days
Sold 4,203 shares at $179.66 ($755k)
Tomasello Shawn, Chief Commercial Officer
Sold 6.4% of holdings ($11.7M position)61,068 shares leftFiling
- 3 Form 4 sale Diplomat Pharmacy, Inc.Plan not statedJun 5 +253 days
Sold 1,680 shares at $24.27 ($41k)
Tomasello Shawn, Director
Sold 13.1% of holdings ($311k position)11,136 shares leftFirst sale on recordFiling
- 4 Form 4 sale Diplomat Pharmacy, Inc.Plan not statedJun 4 +364 days
Sold 1,274 shares at $4.85 ($6k)
Tomasello Shawn, Director
Sold 2.7% of holdings ($226k position)45,396 shares leftFiling
- 5 Form 4 sale Diplomat Pharmacy, Inc.Plan not statedOct 2 +120 days
Sold 859 shares at $4.84 ($4k)
Tomasello Shawn, Director
Sold 1.9% of holdings ($220k position)44,537 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2019 | Diplomat Pharmacy, Inc. | Director | Form 4 sale | 859 | $4k | 1.9% | Plan not stated | SEC |
| Jun 4, 2019 | Diplomat Pharmacy, Inc. | Director | Form 4 sale | 1,274 | $6k | 2.7% | Plan not stated | SEC |
| Jun 5, 2018 | Diplomat Pharmacy, Inc. | Director | Form 4 sale | 1,680 | $41k | 13.1% | Plan not stated | SEC |
| Sep 25, 2017 | Kite Pharma, Inc. | Chief Commercial Officer | Form 4 sale | 4,203 | $755k | 6.4% | Plan not stated | SEC |
| Dec 20, 2016 | Kite Pharma, Inc. | Chief Commercial Officer | Form 4 sale | 4,901 | $249k | 9.0% | Plan not stated | SEC |